Relation
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: London, England, United Kingdom, Europe
Region: England
Country: GB
Continent: Europe
About
Relation is a biotech company focused on discovering transformational medicines through technology-driven biology. It combines high-resolution biology, single-cell multi-omics from patient tissue, functional assays, and machine learning to understand disease from cause to cure. The company operates in drug discovery and development, using Lab-in-the-Loop approaches to identify druggable targets and advance therapies, with a focus on indications such as osteoporosis. Based on collaboration with academia, pharma, and venture partners, Relation aims to accelerate translation from biology to clinical insights across its global team.
Relation is a biotechnology company that utilizes machine learning and high-resolution biology to discover treatments for complex diseases. By integrating single-cell multi-omics with functional assays, the firm identifies druggable targets and advances therapies for conditions such as osteoporosis and neurodegeneration. Its technology-driven approach aims to accelerate the translation of biologic
Relation Therapeutics Inc.
2019
for_profit
active
Industries
Primary Industry: Business Services
Categories
Funding & Financials
Seed
89300000
1m-10m
private
Investors
Founders
Benjamin Swerner
Charles Roberts
Jake Taylor-King
Leadership
Technology Stack
Products
Lab-in-the-Loop Platform: An integrated system combining single-cell analysis, genomics, and machine learning to identify druggable targets and develop medicines.
Therapeutic Development for Osteoporosis: Development of novel therapies targeting osteoporosis using single-cell biology and machine learning.
Strategic Collaborations for Fibrotic Diseases and Osteoarthritis: Partnerships to advance therapeutic development for fibrotic diseases and osteoarthritis using integrated biological and computational methods.